Q4 2016 Ascendis Pharma Earnings Conference Call (Replay)
03/22/17 at 4:30 p.m. ET
Ascendis Pharma ENDO Data Review (Live)
04/03/17 at 4:30 p.m. ET
Ascendis Pharma is a clinical stage biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs.
|Recent News||More >>|
|Upcoming Events||More >>|
|Primary IR Contact|
|Scott T. Smith|
Chief Financial Officer
Data provided by Nasdaq. Minimum 15 minutes delayed.